BMC Pharmacology


Open Access Research article

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

Carlos M Galmarini*, Marilyn L Clarke, Lars Jordheim, Cheryl L Santos, Emeline Cros, John R Mackey and Charles Dumontet

BMC Pharmacology 2004, 4:8 doi:10.1186/1471-2210-4-8

No comments have yet been made on this article.

Post a comment